April 20, 2018 1:34 AM ET


Company Overview of Soleno Therapeutics, Inc.

Key Executives for Soleno Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Anish Bhatnagar 11 RelationshipsPresident, CEO, Principal Financial & Accounting Officer and Director47
Jonathan R. Wolter No RelationshipsInterim Chief Financial Officer67
Neil M. Cowen Ph.D., MBANo RelationshipsSenior Vice President of Drug Development--
Anthony Wondka No RelationshipsSenior Vice President of Research & Development55

Soleno Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Ernest Mario 272 RelationshipsApothogen, Inc.78
Anish Bhatnagar 11 RelationshipsSoleno Therapeutics, Inc.47
William G. Harris 11 RelationshipsXenoport, Inc.59
Mahendra Gopaldas Shah 58 RelationshipsSemnur Pharmaceuticals, Inc.72
James W. Glasheen 39 RelationshipsTechnology Partners50
View All Board Members

Soleno Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee William G. Harris11 Relationships3 Executives
Compensation Committee Mahendra Gopaldas Shah58 Relationships3 Executives
Nominating Committee James W. Glasheen39 Relationships3 Executives
Corporate Governance Committee James W. Glasheen39 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$460.0K
Compensation as of Fiscal Year 2016
Soleno Therapeutics, Inc. CEO Compensation
Industry Average


Phylogica Announces Management Changes
April 10, 2018 11:43 PM ET
Rosetta Genomics Ltd. Announces Resignation of Ken Berlin as President and CEO, Effective April 18, 2018
April 10, 2018 8:04 PM ET
ReNeuron Group plc Announces Executive Changes
April 10, 2018 12:00 PM ET
ProQR Therapeutics N.V. Appoints Dr. Peter A. Beal to Scientific Advisory Board
April 10, 2018 11:00 AM ET
Collagen Solutions plc Appoints Louis T. Ruggiero as Chief Business Officer effective as of 16 April 2018
April 10, 2018 6:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Soleno Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.